These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 15633446)
21. Activation of endothelial and coagulation systems in left ventricular assist device recipients. John R; Panch S; Hrabe J; Wei P; Solovey A; Joyce L; Hebbel R Ann Thorac Surg; 2009 Oct; 88(4):1171-9. PubMed ID: 19766802 [TBL] [Abstract][Full Text] [Related]
22. Improving outcomes with long-term "destination" therapy using left ventricular assist devices. Long JW; Healy AH; Rasmusson BY; Cowley CG; Nelson KE; Kfoury AG; Clayson SE; Reid BB; Moore SA; Blank DU; Renlund DG J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1353-60; discussion 1360-1. PubMed ID: 18544385 [TBL] [Abstract][Full Text] [Related]
23. Does continuous flow left ventricular assist device technology have a positive impact on outcome pretransplant and posttransplant? Klotz S; Stypmann J; Welp H; Schmid C; Drees G; Rukosujew A; Scheld HH Ann Thorac Surg; 2006 Nov; 82(5):1774-8. PubMed ID: 17062246 [TBL] [Abstract][Full Text] [Related]
24. Left ventricular device as destination therapy: are we there yet? Badiwala MV; Rao V Curr Opin Cardiol; 2009 Mar; 24(2):184-9. PubMed ID: 19532106 [TBL] [Abstract][Full Text] [Related]
25. Hospital costs for left ventricular assist devices for destination therapy: lower costs for implantation in the post-REMATCH era. Miller LW; Nelson KE; Bostic RR; Tong K; Slaughter MS; Long JW J Heart Lung Transplant; 2006 Jul; 25(7):778-84. PubMed ID: 16818120 [TBL] [Abstract][Full Text] [Related]
26. Clinical experience with sternotomy versus subcostal approach for exchange of the HeartMate XVE to the HeartMate II ventricular assist device. Gregoric ID; Bruckner BA; Jacob L; Kar B; Cohn WE; La Francesca S; Frazier OH Ann Thorac Surg; 2008 May; 85(5):1646-9. PubMed ID: 18442556 [TBL] [Abstract][Full Text] [Related]
27. [The application of electric heart assist devices in 3 patients with end-stage heart failure as a bridge to transplantation]. Maat AP; Vantrimpont PJ; Bekkers JA; van Thiel RJ; Balk AH; Bogers AJ Ned Tijdschr Geneeskd; 2002 Feb; 146(8):373-7. PubMed ID: 11887625 [TBL] [Abstract][Full Text] [Related]
28. End-organ function in patients on long-term circulatory support with continuous- or pulsatile-flow assist devices. Radovancevic B; Vrtovec B; de Kort E; Radovancevic R; Gregoric ID; Frazier OH J Heart Lung Transplant; 2007 Aug; 26(8):815-8. PubMed ID: 17692785 [TBL] [Abstract][Full Text] [Related]
29. Improved durability of the HeartMate XVE left ventricular assist device provides safe mechanical support up to 1 year but is associated with high risk of device failure in the second year. Martin J; Friesewinkel O; Benk C; Sorg S; Schultz S; Beyersdorf F J Heart Lung Transplant; 2006 Apr; 25(4):384-90. PubMed ID: 16563965 [TBL] [Abstract][Full Text] [Related]
30. Initial clinical experience with the VentrAssist left ventricular assist device: the pilot trial. Esmore DS; Kaye D; Salamonsen R; Buckland M; Begg JR; Negri J; Ayre P; Woodard J; Rosenfeldt FL J Heart Lung Transplant; 2008 May; 27(5):479-85. PubMed ID: 18442712 [TBL] [Abstract][Full Text] [Related]
38. Can the Seattle heart failure model be used to risk-stratify heart failure patients for potential left ventricular assist device therapy? Levy WC; Mozaffarian D; Linker DT; Farrar DJ; Miller LW; J Heart Lung Transplant; 2009 Mar; 28(3):231-6. PubMed ID: 19285613 [TBL] [Abstract][Full Text] [Related]
39. Heart transplant and left ventricular assist device costs. Digiorgi PL; Reel MS; Thornton B; Burton E; Naka Y; Oz MC J Heart Lung Transplant; 2005 Feb; 24(2):200-4. PubMed ID: 15701438 [TBL] [Abstract][Full Text] [Related]
40. Implantable defibrillator with left ventricular assist device compatibility. Oswald H; Klein G; StrĂ¼ber M; Gardiwal A Interact Cardiovasc Thorac Surg; 2009 May; 8(5):579-80. PubMed ID: 19223309 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]